Preview

HIV Infection and Immunosuppressive Disorders

Advanced search

EVALUATION OF PERINATAL HIV TRANSMISSION RISK FACTORS

https://doi.org/10.22328/2077-9828-2014-6-3-32-38

Abstract

The outcomes of perinatal exposure to HIV in neonates born to HIV infected mothers were reviewed retrospectively to characterize perinatal HIV transmission risk factors and their effects on the possibility of HIV transmission to neonates. It was found that the routes of HIV contracting by mothers did not significantly influence perinatal HIV transmission. HIV detection in mothers immediately upon delivery was associated with a higher risk of HIV contracting by their babies compared with the cases of an earlier HIV detection, probably, because of the earlier onsets of chemopreventive interventions in the latter cases. Chemoprevention started at the 36th week of gestation or later was found to provide no benefits with regard to the reduced risk of perinatal HIV transmission compared with the cases of no chemoprevention throughout gestation. Breastfeeding was found to be associated with a significantly increased risk of HIV transmission. These findings made the basis to suggest criteria of the high risk of adverse outcomes of perinatal contact with HIV depending on the organisation of regular medical check-ups of pregnant women and provided evidence of the advantageousness of the earlier choice and onset of chemoprevention using triple therapy. The efficacies of complete and different variants of incomplete regimens of chemoprevention are compared in the present report.

About the Author

E. E. Kuzovatova
Federal Budget Institution of Science «Nizhny Novgorod Scientific and Research Institute of Epidemiology and Microbiology named after Academician I.N.Blokhina» of Federal Service on Surveillance for Consumer Rights Protection and Human Welfare (Rospotrebnadzor)
Russian Federation


References

1. Tubiana R., Le Chenadec J., Rouzioux C., Mandelbrot L., Hamrene K, Dollfus C., Faye A., Delaugerre C., Blanche S, Warszawski J. Factors Associated with Mother-to-Child Transmission of HIV-1 Despite a Maternal Viral Load № 500 Copies/mL at Delivery: A Case-Control Study Nested in the French Perinatal Cohort (EPF-ANRS CO1) // Clin. Infect. Dis.- 2010.- Vol. 50. - Р. 585-596.

2. Eрамова И., Матик С., Мунц М. Профилактика передачи ВИЧ от матери ребенку. В кн.: Лечение и помощь при ВИЧ/СПИДе. Клинические протоколы для Европейского региона ВОЗ.- Копенгаген: Европейское бюро ВОЗ, 2007.- Р. 409-436.

3. Афонина Л.Ю., Воронин Е.Е., Фомин Ю.А., Козырина Н.В., Юрин О.Г., Покровский В.В. Применение антиретровирусных препаратов в комплексе мер, направленных на профилактику передачи ВИЧ от матери ребенку. Клинический протокол // Эпидемиология и инфекционные болезни. Актуальные вопросы.- 2013.- Приложение № 1/2013.- 16 с.

4. Кузоватова Е.Е. Влияние вирусологических и иммунологических показателей матери и способа родоразрешения на исход перинатального контакта у детей, рожденных ВИЧ-позитивными матерями в Приволжском федеральном округе в 2006-2011 гг. // Эпидемиология и инфекционные болезни. Актуальные вопросы.- 2013.- № 6.- С. 43-48

5. Amita G., Bhosale R., Kinikar A., Gupte N., Bharadwaj R., Kagal A., Joshi S., KhandekarM., Karmarkar A., Kulkarni V., Sastry J., Mave V., Suryavanshi N., ThakarM., Kulkarni S., Tripathy S., Sambarey P., Patil S., Paranjape R., BollingerR.C., Jamkar A. Maternal Tuberculosis: A Risk Factor for Mother-to-Child Transmission of Human Immunodeficiency Virus // The Journal of Infectious Diseases 2011.- Vol. 203.- Р. 358-363.

6. Рахманова А.Г., Ястребова Е.Б., Самарина А.В. Организация и результаты медико-социальной помощи женщинам и детям, живущим с ВИЧ // ВИЧ-инфекция и иммуносупрессия.- 2012.- Т. 4, № 1.- С.9-19

7. Mofenson L.M. Protecting the next generation - eliminating perinatal HIV-1 infection // N. Engl. J. Med.- 2010.- Vol. 362 (24).- Р. 2316-2318.

8. Dryden-Peterson S., Jayeoba O., Hughes M., Jibril H., Keapoletswe K., Tlale J., Modise T., Asmelash A., Moyo S., van Widenfelt E., Makhema J., Essex M., Shapiro R.L., Lockman S. Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana // J. Acquir. Immune. Defic. Syndr.- 2011.- Vol. 58.- Р. 353-357.

9. Женщина, ребенок и ВИЧ / Под ред. Н.А.Белякова, Н.Ю.Рахманиной, А.Г.Рахмановой.- СПб.: Балтийский медицинский образовательный центр, 2012.- 600 с.


Review

For citations:


Kuzovatova E.E. EVALUATION OF PERINATAL HIV TRANSMISSION RISK FACTORS. HIV Infection and Immunosuppressive Disorders. 2014;6(3):32-38. (In Russ.) https://doi.org/10.22328/2077-9828-2014-6-3-32-38

Views: 518


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2077-9828 (Print)